Milwaukee, Wisconsin (June 2012) - Dr. Marc D. Brown, president of the American College of Mohs Surgery (ACMS) ( www.skincancermohssurgery.org), says that increases in the use of Mohs surgery for skin cancer treatment have been substantiated now that appropriate use criteria for the procedure have been adopted.
At its annual meeting this spring in San Diego, the American Academy of Dermatology
, in collaboration with the ACMS
, approved the final guidelines.
"The new appropriate use criteria support the effectiveness of Mohs surgery as a treatment for many types of skin cancer, particularly non-melanoma skin cancer," Dr. Brown
is quick to point out that there are several factors that contributed to the increase in Mohs procedures.
explains that Mohs
is a very cost-effective way to treat skin cancer as well.
A graduate of Georgetown University School of Medicine and a professor of dermatology and oncology at University of Rochester Medical Center, Dr. Marc D. Brown is the current president of the American College of Mohs Surgery (www.skincancermohssurgery.org).
Dr. Brown performs Mohs surgery on more than 2,000 patients a year and is a frequent teacher and lecturer at local and national meetings focusing on Mohs surgery, melanoma, facial reconstruction and challenging and unusual skin cancers.